Drugs & TargetsFree Kisqali gets FDA approval as first-line treatment for HR+/HER2- metastatic breast cancer in combination with any aromatase inhibitor March 17, 2017Vol.43 No.11
Drugs & TargetsFree Keytruda gets accelerated approval for classical Hodgkin lymphoma March 17, 2017Vol.43 No.11
Drugs & TargetsFree FDA extends Keytruda PDUFA date for microsatellite instability-high cancer March 17, 2017Vol.43 No.11
Drugs & TargetsFree Mylan announces settlement, license deals with Genentech and Roche on Herceptin March 17, 2017Vol.43 No.11
Drugs & TargetsFree Oncoceutics expands DRD2 research collaborations with NIH March 17, 2017Vol.43 No.11
FreeIn Brief Marshall Hicks named interim president of MD Anderson Cancer Center March 17, 2017Vol.43 No.11
FreeIn Brief Stupp named associate director, strategic initiatives at Lurie Cancer Center March 17, 2017Vol.43 No.11
FreeIn Brief City of Hope vice provost to focus on faculty growth initiatives March 17, 2017Vol.43 No.11
FreeIn Brief Penson named chair of Science & Quality Council at American Urological Association March 17, 2017Vol.43 No.11
